Nascent Health Clinics

Stem Cell IV Therapy

Cell Division, generic cell dividing with copy space, stem cells dividing

Understanding Regenerative Medicine Science

Regenerative medicine represents a rapidly advancing field focused on harnessing the body’s natural healing mechanisms. At Nascent Health Clinics, we utilize cutting-edge, minimally manipulated cellular therapies derived from umbilical cord tissue to support your body’s regenerative potential.

What Makes Our Approach Different?

Our regenerative therapies utilize umbilical cord-derived mesenchymal cells and exosomes that are processed using FDA-compliant methods and filtered through 40-micron filters for safe intravenous administration. These products contain billions of naturally occurring growth factors, cytokines, and regenerative elements.

Clinical Research Foundation

Our therapeutic approaches are grounded in peer-reviewed scientific research exploring the potential of mesenchymal cell-based therapies across multiple applications.

Umbilical Cord-Derived Cells

Research demonstrates that umbilical cord-derived mesenchymal cells possess remarkable regenerative potential. A 2022 study published in Stem Cell Research & Therapy showed these cells can ameliorate age-associated tissue dysfunction by modulating cellular damage and supporting mitochondrial health.

Reference: Piao, L., Huang, Z., Inoue, A., Kuzuya, M., & Cheng, X. W. (2022). Human umbilical cord derived mesenchymal stromal cells ameliorate aging-associated skeletal muscle atrophy and dysfunction by modulating apoptosis and mitochondrial damage in SAMP10 mice. Stem Cell Research & Therapy, 13(1), 226.

Musculoskeletal Applications

A comprehensive 2024 review in the International Journal of Molecular Sciences examined cell-based therapies for rotator cuff injuries, highlighting the potential of these approaches in supporting tissue repair mechanisms. 

Reference: Hooper, N., Marathe, A., Jain, N. B., & Jayaram, P. (2024). Cell-Based Therapies for Rotator Cuff Injuries: An Updated Review of the Literature. International Journal of Molecular Sciences, 25(6), 3139.

Wharton's Jelly Applications

Clinical research has investigated Wharton’s jelly-derived therapies for various orthopedic applications. A 2024 retrospective study found promising safety and efficacy profiles for Wharton’s jelly connective tissue allografts in rotator cuff applications.

Reference: Lai, Albert et al. “Safety and Efficacy of Wharton’s Jelly Connective Tissue Allograft for Rotator Cuff Tears: Findings from a Retrospective Observational Study.” Biomedicines vol. 12,4 710. 22 Mar. 2024.

Cartilage and Disc Research

Scientific literature has extensively studied mesenchymal cells in regenerative medicine, particularly focusing on articular cartilage and intervertebral disc applications, demonstrating their potential in supporting natural healing processes.

Reference: Richardson, Stephen M et al. “Mesenchymal stem cells in regenerative medicine: Focus on articular cartilage and intervertebral disc regeneration.” Methods (San Diego, Calif.) vol. 99 (2016): 69- 80.

Repeated Dosing Studies

Clinical trial data suggests that repeated administration of umbilical cord-derived mesenchymal cells may be superior to single doses in certain applications, as demonstrated in a controlled randomized Phase I/II trial for knee osteoarthritis.

Reference: Matas, J., Orrego, M., Amenabar, D., Infante, C., Tapia-Limonchi, R., Cadiz, M. I., Alcayaga Miranda, F., González, P. L., Muse, E., Khoury, M., Figueroa, F. E., & Espinoza, F. (2019). Umbilical Cord Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II Trial. Stem Cells Translational Medicine, 8(3), 215–224.

Temporomandibular Joint Research

A 2024 systematic review of preclinical studies examined mesenchymal cell-based therapies for temporomandibular joint repair, providing insights into the regenerative potential of these approaches.

Reference: Jiang, Yuanyuan et al. “Mesenchymal Stem Cell-Based Therapies for Temporomandibular Joint Repair: A Systematic Review of Preclinical Studies.” Cells vol. 13,11 990. 6 Jun. 2024.

Interested in Stem Cell IVs? Call our office today!

We would love to help you feel your best

Get in Touch

We’re here to support you every step of the way on your health journey.

Wharton's Jelly Applications

Clinical research has investigated Wharton’s jelly-derived therapies for various orthopedic applications. A 2024 retrospective study found promising safety and efficacy profiles for Wharton’s jelly connective tissue allografts in rotator cuff applications.

Reference: Lai, Albert et al. “Safety and Efficacy of Wharton’s Jelly Connective Tissue Allograft for Rotator Cuff Tears: Findings from a Retrospective Observational Study.” Biomedicines vol. 12,4 710. 22 Mar. 2024.

Cartilage and Disc Research

Scientific literature has extensively studied mesenchymal cells in regenerative medicine, particularly focusing on articular cartilage and intervertebral disc applications, demonstrating their potential in supporting natural healing processes.

Reference: Richardson, Stephen M et al. “Mesenchymal stem cells in regenerative medicine: Focus on articular cartilage and intervertebral disc regeneration.” Methods (San Diego, Calif.) vol. 99 (2016): 69- 80.

Repeated Dosing Studies

Clinical trial data suggests that repeated administration of umbilical cord-derived mesenchymal cells may be superior to single doses in certain applications, as demonstrated in a controlled randomized Phase I/II trial for knee osteoarthritis.

Reference: Matas, J., Orrego, M., Amenabar, D., Infante, C., Tapia-Limonchi, R., Cadiz, M. I., Alcayaga Miranda, F., González, P. L., Muse, E., Khoury, M., Figueroa, F. E., & Espinoza, F. (2019). Umbilical Cord Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II Trial. Stem Cells Translational Medicine, 8(3), 215–224.

Temporomandibular Joint Research

A 2024 systematic review of preclinical studies examined mesenchymal cell-based therapies for temporomandibular joint repair, providing insights into the regenerative potential of these approaches.

Reference: Jiang, Yuanyuan et al. “Mesenchymal Stem Cell-Based Therapies for Temporomandibular Joint Repair: A Systematic Review of Preclinical Studies.” Cells vol. 13,11 990. 6 Jun. 2024.

Our Comprehensive Approach

Three Pillars of Regenerative Medicine

We offer three distinct categories of regenerative therapies, each with unique mechanisms and applications:

Umbilical Cord-Derived Cells

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Exosome Therapies

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Placental Tissue Matrix

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

1. Umbilical Cord-Derived Cells

Wharton's Jelly:

  • Contains billions of cells, growth factors, and cytokines 
  • Processed through FDA-compliant methods using approved grinding kits
  • Filtered through 40-micron filters for safe IV administration
  • Equally effective as expanded cells for orthopedic applications
  • Proven safety profile for intravenous delivery 

Cord Blood-Derived:

  • Offers systemic distribution potential
  • Approximately 1-3% reaches specialized tissue barriers 
  • Yellow appearance due to blood-derived origin 
  • Suitable for any administration route

2. Exosome Therapies

Naturally occurring vesicles that serve as cellular communication messengers. These products focus on tissue remodeling and signaling pathways rather than cell replacement. Exosomes contain:

  • Growth factors and cytokines 
  • Signaling molecules for tissue communication 
  • Regenerative elements for cellular support

Applications:

  • Hair restoration and growth
  • Facial rejuvenation and anti-aging
  • IV therapy for systemic benefits
  • Combination protocols with cellular therapies

3. Placental Tissue Matrix

Derived from donated placental tissue following healthy C-section deliveries. Provides structural support elements and growth factor reservoirs for targeted applications.

What Diseases Can Stem Cells Help?

Although stem cells aren’t a complete cure for every condition, they can play a powerful role in reducing symptoms, supporting prevention, and enhancing overall health. Stem cell therapy may be beneficial for conditions such as:

  • Autoimmune Diseases: Rheumatoid arthritis, lupus, multiple sclerosis.
  • Degenerative Diseases: Osteoarthritis, spinal cord injuries, macular degeneration.
  • Cardiovascular Diseases: Heart disease, heart attacks.
  • Neurological Concerns: Alzheimer’s, Parkinson’s disease.
  • Chronic Pain: Joint pain, back pain, neuropathic pain.
  • Diabetes
  • Cancer

15 Benefits of Stem Cell IV Therapy

  1. Stronger immune function: Stem cells regenerate immune cells, helping the body fight infections—especially beneficial for those with weakened immunity or autoimmune conditions.

  2. Revitalized cellular repair: Aging slows cell renewal, but stem cells replace damaged or aging cells with healthier ones, improving overall function and vitality.

  3. Lower inflammation: With natural anti-inflammatory properties, stem cells help ease chronic inflammation linked to arthritis, heart disease, and autoimmune disorders.

  4. Faster healing: Stem cell therapy accelerates tissue repair after injuries or surgeries, shortening recovery times and supporting rehabilitation.

  5. Pain relief: By repairing damaged tissues like cartilage, stem cells help reduce pain and discomfort from conditions such as osteoarthritis and sports injuries.

  6. Healthier skin: Stem cells stimulate collagen production, boost elasticity, and encourage new cell growth—reducing wrinkles and signs of aging.

  7. Autoimmune support: Stem cells help regulate immune responses, reducing symptoms in conditions like rheumatoid arthritis, lupus, and multiple sclerosis.

  8. Brain and cognitive health: By repairing neural tissue and promoting new cell growth, stem cells may support memory and cognitive function in disorders such as Alzheimer’s and Parkinson’s.

  9. Heart repair: Stem cells can regenerate damaged heart tissue, improving circulation and overall heart function after cardiovascular events.

  10. Joint mobility: By restoring cartilage and reducing inflammation, stem cells enhance mobility and relieve stiffness and pain in joints.

  11. Anti-aging benefits: Stem cells rejuvenate cells throughout the body—supporting healthier skin, muscles, and organs while slowing visible aging.

  12. More energy: Enhanced cellular health helps boost energy levels and reduce fatigue, particularly in those with chronic fatigue.

  13. Organ support: Stem cells aid in regenerating key organs like the liver, kidneys, and lungs, restoring function and protecting against further damage.

  14. Gut health: By healing the digestive tract, stem cells may ease symptoms of Crohn’s disease, IBS, and other digestive issues.

  15. Disease prevention: Improved regeneration and immunity from stem cell therapy may help reduce the risk of chronic illnesses like diabetes, heart disease, and certain cancers.

Safety and Quality Standards

All our regenerative therapies undergo rigorous third-party testing and quality assurance protocols to ensure safety and consistency.

Processing Standards

FDA-compliant processing methods
40-micron filtration for IV safety
Minimally manipulated products
Comprehensive sterility testing at Eurofins laboratories
2-week culture testing protocols
Endotoxin testing standards

Donor Screening

210-question donor questionnaire
Medical director review process
FDA-specified disease panel testing
Healthy delivery requirements from U.S. based donors
Risk factor assessment protocols

Clinical Experience

Over a decade of clinical experience
Proven safety profile for IV administration
No clotting issues due to proper filtration
Combination therapy protocols available
Ongoing outcome monitoring and follow-up

Personalized Regenerative Medicine

Our approach begins with comprehensive consultation to determine the most appropriate regenerative therapy protocol for your individual needs.

Treatment Process

Step 1: Comprehensive Consultation (60 minutes)

  • Complete medical history review
  • Physical examination
  • Treatment planning and customization
  • Risk assessment and contraindication screening

Step 2: Customized Therapy Administration

  • IV delivery using filtered, safety-tested products 
  • Combination protocols when appropriate 
  • Minimally invasive procedures 
  • Real-time monitoring during administration

Step 3: Follow-up Monitoring

  • 3-month progress assessment 
  • 6-month outcome evaluation 
  • Protocol adjustments as necessary 
  • Long-term care planning

Important Medical Disclaimer

These regenerative medicine therapies have not been evaluated by the FDA and are considered experimental. These products are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. A thorough medical consultation is required to determine candidacy for these therapies.